|
Volumn 12, Issue 13, 2011, Pages 1175-
|
Tapping our immune potential to realise the ultimate goal
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
IPILIMUMAB;
LENALIDOMIDE;
SIPULEUCEL T;
TG 4010;
THALIDOMIDE;
UNCLASSIFIED DRUG;
WART VIRUS VACCINE;
CANCER EPIDEMIOLOGY;
CANCER IMMUNIZATION;
CANCER IMMUNOLOGY;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
EDITORIAL;
HEMATOLOGIC MALIGNANCY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
LUNG NON SMALL CELL CANCER;
MELANOMA;
PAPILLOMAVIRUS INFECTION;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
PROSTATE CANCER;
PUBLICATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
IMMUNOTHERAPY;
NEOPLASMS;
ORGAN TRANSPLANTATION;
RISK FACTORS;
TREATMENT OUTCOME;
TUMOR ESCAPE;
|
EID: 82555192815
PISSN: 14702045
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(11)70348-5 Document Type: Editorial |
Times cited : (2)
|
References (0)
|